Page 1

REALAB Transforming life for patients with Parkinson's disease IRLAB Interim report July - September 2021 Q3 " The license agreement with Ipsen is a milestone for IRLAB - our business model is validated and our scalable research platform ISP provides the conditions to increase the pace in our value creation . "